Crescent Biopharma Inc. (CBIO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    11.72
    -0.31 (-2.58%)
    At close: Oct 03, 2025, 3:59 PM
    11.72
    0.00%
    After-hours: Oct 03, 2025, 05:45 PM EDT

    Crescent Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 34.77M 41.79M 47.87M 90.25M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 813K 757.91K 102.32K 2.15M
    Receivables
    		 136.58K 175.82K 144.02K 1.35K
    Inventory
    		 n/a n/a -144.4K -535.15K
    Other Current Assets
    		 -333.28K n/a 144.02K 535.04K
    Total Current Assets
    		 34.8M 43.79M 50.71M 90.79M
    Property-Plant & Equipment
    		 n/a 767.83K 993.56K 1.95M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 813K 1.53M 1.1M 4.09M
    Total Assets
    		 35.62M 45.32M 51.81M 94.35M
    Account Payables
    		 329.3K 868.12K 970.19K 2.11M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 741.56K 918.55K 1M
    Other Current Liabilities
    		 4.68M 2.22M -918.55K -1M
    Total Current Liabilities
    		 9.61M 6.84M 8.88M 11.82M
    Long-Term Debt
    		 37.48M n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 37.48M 66.84K 1.89M 918.61K
    Total Liabilities
    		 47.1M 6.9M 8.88M 12.74M
    Total Debt
    		 37.48M 808.4K 918.55K 1.92M
    Book Value
    		 -11.48M 38.41M 42.93M 81.6M
    Book Value Per Share
    		 -0.18 0.61 0.82 1.59
    Common Stock
    		 1K 64.39K 54.38K 52.31K
    Retained Earnings
    		 -17.87M -456.49M -419.59M -372.9M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -11.48M 38.41M 42.93M 81.6M
    Total Investments
    		 10.71B n/a n/a n/a

    Add to Watchlist